Top

Published in:

01-12-2021 | Chronic Kidney Disease | EDITORIAL

Choosing between anatomy and function is not always evident for the heart of end-stage renal disease patients. How low can we go?

Author: Amalia Peix

Published in: Journal of Nuclear Cardiology | Issue 6/2021

Abstract

Patients with chronic kidney disease (CKD) are at a very high risk of adverse cardiovascular events. In CKD patients, vascular calcification is more prevalent, appears at an earlier age, and is more severe than in the general population. CKD physiology rather than the effects of dialysis is the primary driver of microvascular disease in these patients. Considering the significant morbidity and mortality attributable to cardiovascular disease in the CKD population, risk stratification remains an important challenge. Topics such as function vs anatomy to properly risk stratify these patients, as well as future perspectives on non-invasive techniques, will be addressed.

Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic kidney disease and coronary artery disease. J Am Coll Cardiol 2019;74:1823-38.CrossRef

Lemos MM, Jancikic AD, Sanches FM, Christofalo DM, Ajzen SA, Carvalho AB, et al. Intima-media thickness is associated with inflammation and traditional cardiovascular risk factors in non-dialysis-dependent patients with chronic kidney disease. Nephron Clin Pract 2010;115:c189-94.CrossRef

Adeseun GA, Xie D, Wang X, Joffe MM, Mohler ER, Townsend RR, et al. Carotid plaque, carotid intima-media thickness, and coronary calcification equally discriminate prevalent cardiovascular disease in kidney disease. Am J Nephrol 2012;36:342-7.CrossRef

London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-40.CrossRef

Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 2009;4:1892-900.CrossRef

Nolan RL, Morton AR, Pickett W. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. Am J Kidney Dis 2008;52:849-58.CrossRef

Cardellini M, Rovella V, Scimeca M, Anemona L, Bischetti S, Casella S, et al. Chronic kidney disease is linked to carotid nodular calcification, an unstable plaque not correlated to inflammation. Aging Dis 2019;10:71-81.CrossRef

Schlieper G, Aretz A, Verberckmoes SC, Krüger T, Behets GJ, Ghadimi R, et al. Ultrastructural analysis of vascular calcifications in uremia. J Am Soc Nephrol 2010;21:689-96.CrossRef

Robinson J, Tan AU, Wilensky RL, Matthai W, Munoz M, Rosas SE. Electron-beam computerized tomography correlates with coronary angiogram in chronic kidney disease patients. Am J Nephrol 2007;27:247-52.CrossRef

10.

Budoff MJ. Screening for ischemic heart disease with cardiac CT: Current recommendations. Scientifica (Cairo) 2012;2012:812046. https://doi.org/10.6064/2012/812046.CrossRef

11.

Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-83.CrossRef

12.

Folsom AR, Kronmal RA, Detrano RC, O’Leary DH, Bild DE, Bluemke DA, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008;168:1333-9.CrossRef

13.

Spacil J, Ceska R, Petrasek J, Sobra J. The effect of four-year hypolipidaemic treatment on the intimal thickness of the common carotid artery in patients with familiar hyperlipidaemia. Int Angiol 1999;18:313-9.PubMed

14.

Sillesen H, Muntendam P, Adourian A, Entrekin R, Garcia M, Falk E, et al. Carotid plaque burden as a measure of subclinical atherosclerosis: Comparison with other tests for subclinical arterial disease in the high risk plaque BioImage Study. J Am Coll Cardiol Img 2012;5:681-9.CrossRef

15.

Wenning C, Vrachimis A, Pavenstädt HJ, Reuter S, Schäfers M. Coronary artery calcium burden, carotid atherosclerotic plaque burden and myocardial blood flow patients with end-stage renal disease: A non-invasive imaging study combining PET/CT and 3D-ultrasound. J Nucl Cardiol 2020. https://doi.org/10.1007/s12350-020-02080-w.CrossRefPubMed

16.

Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004;8:54-8.CrossRef

17.

Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007;71:438-41.CrossRef

18.

Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008;358:1336-45.CrossRef

19.

Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210-5.CrossRef

20.

Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007;49:378-402.CrossRef

21.

Kato A, Takita T, Maruyama Y, Kumagai H, Hishida A. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int 2003;64:1472-9.CrossRef

22.

Ekart R, Hojs R, Hojs-Fabjan T, Balon BP. Predictive value of carotid intima media thickness in hemodialysis patients. Artif Organs 2005;29:615-9.CrossRef

23.

Zoungas S, Cameron JD, Kerr PG, Wolfe R, Muske C, McNeil JJ, et al. Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. Am J Kidney Dis 2007;50:622-30.CrossRef

24.

Gaspar A, Watanabe R, Montebello M, Fernandes ME. Evaluation of intima-media thickness in patients with chronic kidney disease not on dialysis: A prospective study of 24 months. J Bras Nefrol 2014;36:35-41.CrossRef

25.

Hamczyk MR, Nevado RM, Barettino A, Fuster V, Andrés V. Biological versus chronological aging. J Am Coll Cardiol 2020;75:919-30.CrossRef

26.

Einstein AJ, Johnson LL, Bokhari S, Son J, Thompson RC, Bateman TM, et al. Agreement of visual estimation of coronary artery calcium from low-dose CT attenuation correction scans in hybrid PET/CT and SPECT/CT with standard Agatston score. J Am Coll Cardiol 2010;56:1914-21.CrossRef

27.

Xie X, Zhao Y, de Bock GH, de Jong PA, Mali WP, Oudkerk M, et al. Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography: Systematic review and meta-analysis. Circ Cardiovasc Imaging 2013;6:514-21.CrossRef

28.

Dumer S, Einstein A. Coronary calcium scoring of CT attenuation correction scans: Automatic, manual, or visual? J Nucl Cardiol 2018;25:2144-7.CrossRef

29.

Charytan DM, Skali H, Shah NR, Veeranna V, Cheezum MK, Taqueti VR, et al. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int 2018;93:501-9.CrossRef

30.

Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Dorbala S, et al. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging 2012;5:1025-34.CrossRef

31.

Kidney Disease: Improving Global Outcomes Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009;9:S1-155.

32.

Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. KDIGO clinical practice guideline for lipid management in chronic kidney disease. Kidney Int Suppl 2013;3:259-305.CrossRef

33.

Chen Z, Qureshi AR, Brismar TB, Ripsweden J, Haarhaus M, Barany P, et al. Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients. BMC Nephrol 2019;20:59. https://doi.org/10.1186/s12882-019-1235-z.CrossRefPubMedPubMedCentral

34.

Anker SD, Gillespie IA, Eckardt KU, Kronenberg F, Richards S, Drueke TB, for the ARO Steering Committee, et al. Development and validation of cardiovascular risk scores for haemodialysis patients. Int J Cardiol 2016;216:68-77.CrossRef

35.

Valdivielso JM, Rodríguez-Puyol D, Pascual J, Barrios C, Bermúdez-López M, Sánchez-Niño MD, et al. Atherosclerosis in chronic kidney disease: More, less, or just different? Arterioscler Thromb Vasc Biol 2019;39:1938-66.CrossRef

36.

Fiz F, Morbelli S, Piccardo A, Bauckneht M, Ferrarazzo G, Pestarino E, et al. 18F-NaF uptake by atherosclerotic plaque on PET/CT imaging: Inverse correlation between calcification density and mineral metabolic activity. J Nucl Med 2015;56:1019-23.CrossRef

37.

Rosa GM, Bauckneht M, Masoero G, Mach F, Quercioli A, Seitun S, et al. The vulnerable coronary plaque: Update on imaging technologies. Thromb Haemost 2013;110:706-22.CrossRef

38.

Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13.CrossRef

39.

Wang Y, Osborne MT, Tung B, Li M, Li Y. Imaging cardiovascular calcification. J Am Heart Assoc 2018;7:e008564. https://doi.org/10.1161/JAHA.118.008564.CrossRefPubMedPubMedCentral

40.

Figueroa AL, Abdelbaky A, Truong QA, Corsini E, MacNabb MH, Lavender ZR, et al. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. JACC Cardiovasc Imaging 2013;6:1250-9.CrossRef

41.

Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, dal- PLAQUE Investigators, et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): A randomised clinical trial. Lancet 2011;378:1547-59.CrossRef

Title: Choosing between anatomy and function is not always evident for the heart of end-stage renal disease patients. How low can we go?
Author: Amalia Peix
Publication date: 01-12-2021
Publisher: Springer International Publishing
Keyword: Chronic Kidney Disease
Published in: Journal of Nuclear Cardiology / Issue 6/2021
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-020-02118-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Choosing between anatomy and function is not always evident for the heart of end-stage renal disease patients. How low can we go?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2021

Prognostic value of coronary risk factors, exercise capacity and single photon emission computed tomography in liver transplantation candidates: A 5-year follow-up study

Stress myocardial perfusion imaging in patients presenting with syncope: Comparison of PET vs. SPECT

What is this image? 2021 image 3 result

An optimized imaging protocol for [99mTc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis

Prognostic value of myocardial perfusion imaging with D-SPECT camera in patients with ischemia and no obstructive coronary artery disease (INOCA)

Variation in additional testing and patient outcomes after stress echocardiography or myocardial perfusion imaging, according to accreditation status of testing site